Deal Snapshot
PCI PHARMA ACQUIRES BELLWYCK PHARMA SERVICES
Thursday 13 February 2020

US-based pharmaceutical and biopharmaceutical global supply chain solutions provider PCI Pharma Services has acquired Canadian packaging and labeling company Bellwyck Pharma Services serving the clinical trial and commercial drug markets, to expand clinical trial services into Canada and Continental Europe, the company said.
The acquisition will add four GMP-compliant facilities to the PCI network in the US, Germany and Canada. With Canada and Germany ranked third and fourth in the world for total number of clinical trials, respectively.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 13/02/2020
Target: Bellwyck Pharma Services
Country: Canada
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: PCI Pharma Services
Comment:
Terms of the deal were not disclosed

Options